Neurodegeneration – News and Features

NGI has announced Dr. Tannin Fuja, director of research and chief scientific officer, will testify a public hearing in support of the Iowa Stem Cell Research and Cures Initiative.

CIRM's SEED grants will launch projects to explore aspects of stem cell biology in areas of medical relevance disease like Parkinson's and cancer.

Researchers aim to reveal the genetic and environmental causes behind deadly and disabling diseases.

The Company has initiated a safety trial using an animal model of Parkinson’s disease in primates utilizing its adult stem cell technology.

Siemens’ Molecular Imaging research facility is dedicated to the development of molecular imaging biomarkers for identifying debilitating diseases at their earliest stages.

The collaboration provides Ortho-McNeil Pharmaceutical and its affiliate J&JPRD with Cellzome’s Amyloid Precursor Protein processing pathway map.

The Company receives SBIR grant to develop a medical diagnostic test to assess vitamin B12 malabsorption.

The combination of the two approaches will offer an opportunity to develop molecules having disease-modifying therapies for Alzheimer’s disease.

The technology is expected to enhance Max Planck’s neurodegenerative disease research programs.

The agreement worth $265 million is to discover and develop therapies for Alzheimer’s disease using Ablynx’ Nanobodies®.